OJPathology  Vol.5 No.2 , April 2015
Evaluating the Importance of Apoptotic Index, Mitotic Index and Turnover Index in Premalignant and Malignant Lesions of Cervix
Abstract: Aim: To evaluate the premalignant and malignant lesions of the uterine cervix on light microscopy for apoptosis. To calculate and correlate the apoptotic index (AI), mitotic index (MI) and turnover index of the lesions. Materials and methods: A 2-year retrospective (November 2007 to October 2009) and 1-year prospective study (November 2009 to October 2010). A total of 95 cases of premalignant and malignant lesions of cervix were studied. The hematoxylin-eosin stained slides were screened for apoptosis under oil immersion lens. Apoptotic index (AI) was calculated as the number of Apoptotic cells and Apoptotic bodies, expressed as percentage of total no. of tumour cells counted in each case. Mitotic index (MI) was calculated by counting mitosis among 1000 tumour cells. Turnover index (TOI) was obtained by adding MI and AI, i.e., (TOI = MI + AI). After calculating, all these indices were correlated with different grades of the cervical lesions. Results: Premalignant lesions were divided into four subgroups. On statistical analysis, it was found that the difference in the apoptotic indices and turnover indices in all the four subgroups was not statistically significant. However for mitotic indices, significant statistical difference was found in Subgroup II (mild dysplasia vs. moderate dysplasia) with a p value of 0.03 and in subgroup IV (squamous metaplasia vs. moderate/severe dysplasia) with a p value of 0.0005. Within the malignant group, we compared well differentiated with less well differentiated subgroup. Statistical analysis revealed a significant difference in TOI between the two subgroups of malignant tumours (p = 0.04). Statistical comparison between premalignant and malignant group of lesions showed a highly significant difference between the AI, MI and TOI with p value of 0.0001. Conclusion: We conclude that proliferative and apoptotic indices are useful in distinguishing between benign and malignant lesions of the cervix. Proliferative activity of a lesion is a reliable indicator of its malignant potential and together with apoptotic count gives an idea about the net growth of a tumour.
Cite this paper: Bhardwaj, S. and Wani, F. (2015) Evaluating the Importance of Apoptotic Index, Mitotic Index and Turnover Index in Premalignant and Malignant Lesions of Cervix. Open Journal of Pathology, 5, 29-37. doi: 10.4236/ojpathology.2015.52005.

[1]   Lockshin, R.A. and Zakeri, Z. (2007) Cell Death in Health and Disease. Journal of Cellular and Molecular Medicine, 11, 1214-1224.

[2]   Kerr, J.F., Wyllie, A.H. and Currie, A.R. (1972) Apoptosis: A Basic Biological Phenomenon with Wide-Ranging Implications in Tissue Kinetics. British Journal of Cancer, 26, 239-257.

[3]   Lane, D.P. (1992) p53, Guardian of the Genome. Nature, 358, 15-16.

[4]   Vogelstein, B. and Kinzler, K.W. (1992) p53 Function and Dysfunction. Cell, 70, 523-526.

[5]   Schimke, R.T., Kung, A., Sherwood, S.S., Sheridan, J. and Sharma, R. (1995) Life, Death and Genomic Change in Perturbed Cell Cycles. In: Dexter, T.M., Raff, M.C. and Wyllie, A.H., Eds., The Role of Apoptosis in Development, Tissue Homeostasis and Malignancy, Chapman and Hall, London, 75-81.

[6]   Symonds, H., Krall, L., Remington, L., Saenz-Rubles, M., Lowe, S., Jacks, T. and Van, D.T. (1994) P53-Dependent Apoptosis Suppresses Tumour Growth and Progression in Vivo. Cell, 78, 703-711.

[7]   Kerr, J.F.R., Winterford, C.M. and Harman, B.V. (1994) Apoptosis: Its Significance in Cancer and Cancer Therapy. Cancer, 73, 2013-2026.<2013::AID-CNCR2820730802>3.0.CO;2-J

[8]   Darzynkiewicz, Z. (1995) Apoptosis in Anti Tumour Strategies: Modulation of Cell Cycle or Differentiation. Journal of Cellular Biochemistry, 58, 151-159.

[9]   Lipponen, P., Aaltomaa, S., Kosma, V.M. and Syrjänen, K. (1994) Apoptosis in Breast Cancer as Related to Histopathological Characteristics and Prognosis. European Journal of Cancer, 30A, 2068-2073.

[10]   Lipponen, P.K. and Aaltomaa, S. (1994) Apoptosis in Bladder Cancer as Related to Standard Prognostic Factors and Prognosis. The Journal of Pathology, 173, 333-339.

[11]   Stapleton, A.M.F., Zhell, P., Kattan, M.W., Yang, G., Wheeler, T.M., Schardino, P.T. and Thompson, T.C. (1998) Assessment of the Biologic Markers p53, Ki-67, and Apoptotic Index as Predictive Indicators of Prostatic Carcinoma Recurrence after Surgery. Cancer, 82, 168-173.<168::AID-CNCR21>3.0.CO;2-#

[12]   Törmanen, U., Eerola, A.K., Rainio, P., Vahakanagas, K., Soini, Y., Sormunen, R., Bloigu, R., Lehto, V.P. and Paakkö, P. (1995) Enhanced Apoptosis Predicts Shortened Survival in Non-Small Cell Lung Carcinoma. Cancer Research, 55, 5595.

[13]   Yao, K.S., Clayton, M. and O’Dwyer, P.J. (1995) Apoptosis in Human Adeocarcinoma HT29 Cells Induced by Exposure to Hypoxia. Journal of the National Cancer Institute, 87, 117-122.

[14]   Kinzlar, K.W. and Vogelstein, B. (1996) Life (and Death) in a Malignant Tumour. Nature, 379, 19-20.

[15]   Harrison, D.J. (1996) Counting Apoptosis—Why and How? Journal of Clinical Pathology-Molecular Pathology, 49, 245-246.

[16]   Ansari, B., Coates, P.J., Greenstein, B.D. and Hall, P.A. (1993) In Situ End-Labelling Detects DNA Strand Breaks in Apoptosis and Other Physiological and Pathological States. The Journal of Path-ology, 170, 1-8.

[17]   Gavrieli, Y., Sherman, Y. and Ben-Sasson, S.A. (1992) Identification of Programmed Cell Death in Situ via Specific Labeling of Nuclear DNA Fragmentation. Journal of Cell Biology, 119, 493-501.

[18]   Mishra, G.A., Pimple, S.A. and Shastri, S.S. (2011) An Overview of Prevention and Early Detection of Cervical Cancers. Indian Journal of Medical and Paediatric Oncology, 32, 125-132.

[19]   Crum, C.P. (2004) The Female Genital Tract. In: Kumar, V., Abbas, A.K. and Fausto, N., Eds., Robbins and Cotran, Pathologic Basis of Disease, 7th Edition, WB Saunders Company Elsevier Inc., Phil-adelphia, 1072-1079.

[20]   Mysorekar, V.V., David, S. and Rao, S.G. (2008) Proliferative and Apoptotic Indices in Squamous Epithelial Lesions of the Cervix. Bahrain Medical Bulletin, 30, 156-159.

[21]   Ferlay, J., Shin, H.R., Bray, F., Forman, D., Mathers, C. and Parkin, D.M. (2010) Estimates of Worldwide Burden of Cancer in 2008: GLOBOCAN 2008. International Journal of Cancer, 127, 2893-2917.

[22]   Dey, P., Das, R. and Sabuddin (2000) Correlations between Apoptotic and Proliferative Indices in Cervical Intraepithelial Neoplasia and Carcinoma. Indian Journal of Pathology & Microbiology, 43, 271-275.

[23]   Hall, P.A., Levison, D.A., Woods, A.L., Yu, C.C., Kellock, D.B., Watkins, J.A., Barnes, D.M., Gillett, C.E., Camplejohn, R., Dover, R., et al. (1990) Proliferating Cell Nuclear Antigen (PCNA) Immunolocalization in Paraffin Sections: An Index of Cell Proliferation with Evidence of Deregulated Expression in Some Neoplasms. The Journal of Pathology, 162, 285-294.

[24]   Sugamura, K., Makino, M. and Kaibara, N. (1998) Apoptosis as a Prognostic Factor in Colorectal Carcinoma. Surgery Today (Tokyo), 28, 145-150.

[25]   Heatley, M.K. (1995) Association between the Apoptotic Index and Established Prognostic Parameters in Endometrial Adenocarcinoma. Histopathology (Oxford), 27, 469-472.

[26]   Aihara, M., Truong, L.D., Dunn, J.K., Wheeler, T.M., Scardino, P.T. and Thompson, T.C. (1994) Frequency of Apoptotic Bodies Positively Correlates with Gleason Grade in Prostate Cancer. Human Pathology, 25, 797-801.

[27]   Sagol, O., Yorukoglu, K., Sagol, S., Koyuncuoglu, M. and Uslu, T. (1999) Apoptotic and Mitotic Index in Squamous Cell Carcinomas and Premalignant Lesions of the Uterine Cervix. International Journal of Surgical Pathology, 7, 155-160.

[28]   Pahuja, S., Choudhury, M. and Gupta, U. (2003) Proliferative Activity in Squamous Intraepithelial and Invasive Lesions of Cervix: Analysis by AgNOR Staining. Indian Journal of Pathology & Microbiology, 46, 573-575.